Page last updated: 2024-08-24
goralatide and Complications of Diabetes Mellitus
goralatide has been researched along with Complications of Diabetes Mellitus in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Kanasaki, K | 1 |
Bombardi, C; Castoldi, G; Corradi, B; di Gioia, CR; Leopizzi, M; Mancini, M; Perego, C; Perego, L; Perlini, S; Stella, A; Zerbini, G | 1 |
Reviews
1 review(s) available for goralatide and Complications of Diabetes Mellitus
Article | Year |
---|---|
N-acetyl-seryl-aspartyl-lysyl-proline is a valuable endogenous antifibrotic peptide for kidney fibrosis in diabetes: An update and translational aspects.
Topics: Animals; Diabetes Complications; Fibrosis; Humans; Kidney; Kidney Diseases; Oligopeptides; Peptidyl-Dipeptidase A; Signal Transduction | 2020 |
Other Studies
1 other study(ies) available for goralatide and Complications of Diabetes Mellitus
Article | Year |
---|---|
Prevention of myocardial fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in diabetic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomyopathies; Diabetes Complications; Diabetes Mellitus, Experimental; Fibrosis; Heart Ventricles; Hypoglycemic Agents; Insulin; Male; Myocardium; Oligopeptides; Ramipril; Rats; Rats, Sprague-Dawley; Smad Proteins; Transforming Growth Factor beta1 | 2009 |